Patient information on anatomy, diagnosis and treatment options 

Patient guide on talking to their doctor 

Patient heart anatomy consultation guide 

Patient heart health tracking diary

For people caring for a loved one with aortic stenosis (AS)

A patient guide to transcatheter aortic valve implantation (TAVI)

Aortic stenosis: an overview

Asymptomatic aortic stenosis: the importance of stress testing 

TAVI in bicuspid aortic valve patients. Edwards SAPIEN 3 Platform, a safe and efficient option (1:23:00)

Bicuspid aortic valve – The key differences between bicuspid and tricuspid AS patients (21:00)

Bicuspid aortic valve live-in-a-box case 1 (German Heart Center Berlin) (21:00)

The typical challenges you face during bicuspid TAVI procedures (01:15)

The future for TAVI in bicuspid aortic stenosis patients (01:27)

How to prevent complications during a TAVI procedure in bicuspid AS patients (1:20)

TAVI Today shared case series: TAVI in bicuspid aortic valves (33:00)

5-year outcomes comparing surgical versus transcatheter aortic valve replacement in patients with chronic kidney disease

Impact of predilation during transcatheter aortic valve replacement. Insights from the PARTNER 3 Trial

Prosthesis-patient mismatch after aortic valve replacement in the PARTNER II Trial and Registry

Utilisation, costs, and outcomes of conscious sedation versus general anesthesia for transcatheter aortic valve replacement

Paravalvular regurgitation post-transcatheter aortic valve replacement in intermediate risk patients: a pooled PARTNER II study

The balloon expandable study compendium

Echocardiography - Roles and limitations in measuring valve function (47:00)

The ESC/EACTS 2021 pocket guidelines brochure 

2021 ESC/EACTS VHD guidelines infographic

Find out how Edwards SAPIEN 3 TAVI is superior to surgery for low-risk sAS patients 

Working internally to expand the TAVI service: Interview with Dr John Rawlins, Consultant Interventional Cardiologist

Accelerating TAVI adoption video Interview with Professor Dave Smith (07:06)

See how TAVI’s low hospital footprint enables more of your patients to be treated sooner

Enhancing quality of care for patients with an optimised TAVI program: Italian center experience

How seamless communication and co-ordination provides increased value to patients

Improving your patient's outcomes with the Edwards Benchmark program

Accelerating patient discharge for better patient outcomes: Edwards Benchmark program, French center experience

Delivering better patient outcomes with a contemporary approach: German center experience

Watch a patient journey through Edwards Benchmark program

See the 3M economic study data presented at TVT 2021

PARTNER 3 Trial - See the latest follow-up results

PARTNER 3 Trial - Access the original 1 yr data

PARTNER 3 Trials - Read the QoL data

See the PARTNER 3 Trial outcomes infographic

Partner II Trial showed comparable outcomes for Edwards SAPIEN 3 TAVI vs SAVR in intermediate-risk patients.

PARTNER 1A Trial - Read the initial 1yr follow up

PARTNER 1A Trial: Find out the subsequent 5yr follow up data

PARTNER 1B Trial - Read the initial 1yr follow up

PARTNER 1B Trial -Discover the subsequent 5yr follow up

Edwards SAPIEN 3 Ultra valve - built for coronary access

The Higher Standards you can meet with Edwards SAPIEN 3 Ultra valve 

Edwards Benchmark program

Coronary Access Summary Brochure SAPIEN 3 Ultra Valve

THV-in-THV Summary Brochure SAPIEN 3 Ultra Valve

First Valve Choice Considerations

Excellence in Paravalvular Leak (PVL) Performance

Designed to Host Future Valve Interventions (THV-in-THV)

Edwards SAPIEN 3 platform

A Comprehensive Approach to Durability

Facilitating Future Coronary Access

Contemporary results with the SAPIEN 3 Ultra RESILIA valve

Clinical outcomes of balloon expandable valves in small annuli: the latest data

Durability: what does the patient care about?

TAVR Results in Small Annuli Patients: Early Reactions to New Data

Coffee Talk at ACC 2024 with Dr. Vinod Thourani and Dr. Philippe Généreux

SAPIEN 3 TAVR: a therapy with durable outcomes through 5 years, including for small annulus and female patients

RHEIA Clinical Summary

RHEIA General Cardiologist Study Design

RHEIA Implanter Study Design